Lisdexamfetamine and Secondary Raynaud's Phenomenon

Prim Care Companion CNS Disord. 2018 Sep 13;20(5):17l02240. doi: 10.4088/PCC.17l02240.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Central Nervous System Stimulants / adverse effects*
  • Humans
  • Lisdexamfetamine Dimesylate / adverse effects*
  • Male
  • Raynaud Disease / chemically induced*

Substances

  • Central Nervous System Stimulants
  • Lisdexamfetamine Dimesylate